Fmr LLC Keros Therapeutics, Inc. Transaction History

Fmr LLC

$1.68 Trillion
Q2 2025

A detailed history of Fmr LLC transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 164,271 shares of KROS stock, worth $2.26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

164,271

Previous 441,540 62.8%

Holding current value

$2.26 Million

Previous $4.5 Million 51.26%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$9.55 - $15.11 $2.65 Million - $4.19 Million	-277,269 Reduced 62.8%	164,271 $2.19 Million
Q1 2025 May 12, 2025	SELL	$10.15 - $16.1 $51.8 Million - $82.1 Million	-5,101,768 Reduced 92.03%	441,540 $4.5 Million
Q4 2024 Feb 13, 2025	BUY	$15.64 - $70.0 $10.1 Million - $45.1 Million	644,174 Added 13.15%	5,543,308 $87.8 Million
Q3 2024 Nov 13, 2024	BUY	$41.68 - $58.07 $7.48 Million - $10.4 Million	179,374 Added 3.8%	4,899,134 $284 Million
Q2 2024 Aug 13, 2024	SELL	$44.58 - $66.89 $13.3 Million - $20 Million	-298,756 Reduced 5.95%	4,719,760 $216 Million
Q1 2024 May 13, 2024	BUY	$41.26 - $70.48 $47.2 Million - $80.7 Million	1,144,312 Added 29.54%	5,018,516 $332 Million
Q4 2023 Feb 13, 2024	BUY	$27.12 - $41.05 $7.3 Million - $11.1 Million	269,276 Added 7.47%	3,874,204 $154 Million
Q3 2023 Nov 13, 2023	SELL	$31.57 - $43.02 $14.3 Million - $19.5 Million	-454,113 Reduced 11.19%	3,604,928 $115 Million
Q2 2023 Aug 11, 2023	BUY	$37.26 - $51.01 $267,079 - $365,639	7,168 Added 0.18%	4,059,041 $163 Million
Q1 2023 May 11, 2023	BUY	$41.44 - $59.32 $15.4 Million - $22.1 Million	372,784 Added 10.13%	4,051,873 $173 Million
Q4 2022 Feb 13, 2023	SELL	$39.45 - $51.77 $7.28 Million - $9.55 Million	-184,437 Reduced 4.77%	3,679,089 $177 Million
Q3 2022 Nov 10, 2022	BUY	$27.8 - $40.12 $7.33 Million - $10.6 Million	263,631 Added 7.32%	3,863,526 $145 Million
Q2 2022 Aug 12, 2022	BUY	$26.03 - $67.04 $15.4 Million - $39.7 Million	591,959 Added 19.68%	3,599,895 $99.5 Million
Q1 2022 May 13, 2022	SELL	$42.12 - $59.36 $20.9 Million - $29.5 Million	-496,862 Reduced 14.18%	3,007,936 $164 Million
Q4 2021 Feb 14, 2022	BUY	$36.95 - $62.89 $152,197 - $259,043	4,119 Added 0.12%	3,504,798 $205 Million
Q3 2021 Nov 15, 2021	BUY	$29.27 - $43.71 $179,717 - $268,379	6,140 Added 0.18%	3,500,679 $138 Million
Q2 2021 Aug 13, 2021	BUY	$42.4 - $70.11 $148 Million - $245 Million	3,494,539 New	3,494,539 $148 Million

Others Institutions Holding KROS

# of Institutions

157

Shares Held

38.7M

Call Options Held

834K

Put Options Held

969K

View Full List

About Keros Therapeutics, Inc.

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $354M
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

More about KROS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account